Effects of Targeted Neuronal Nitric Oxide Synthase Gene Disruption and Nitro sup G -L-Arginine Methylester on the Threshold for Isoflurane Anesthesia
Open Access
- 1 July 1995
- journal article
- laboratory investigations
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 83 (1) , 101-108.
- https://doi.org/10.1097/00000542-199507000-00013
Abstract
Background: Considerable evidence suggests that nitric oxide plays a role in synaptic transmission in the central and peripheral nervous system. Nonselective inhibition of nitric oxide synthase by nitroG-L-arginine methylester (L-NAME) reduces the minimum alveolar concentration of halothane anesthesia. The effects of selective neuronal nitric oxide synthase inhibition on the anesthetic requirements in mice congenitally deficient in neuronal nitric oxide synthase (knockout mice) were examined. Methods: Isoflurane minimum alveolar concentration and righting reflex ED50 (RRED50) were determined in knockout and wild-type mice. Subsequently, the effects of intraperitoneal L-NAME on minimum alveolar concentration and RRED50 of knockout and wild-type mice were examined. In a separate experiment, the effects of week-long administration of L-NAME were examined in wild-type mice. Isoflurane minimum alveolar concentration and RRED50 were measured on the 8th day and were repeated after an acute intraperitoneal dose of L-NAME. Results: Targeted disruption of the neuronal nitric oxide synthase gene did not modify isoflurane minimum alveolar concentration and RRED50 of knockout mice. Acute intraperitoneal L-NAME decreased the minimum alveolar concentration and RRED50 of wild-type but did not alter those values in knockout mice. The wild-type mice, when given L-NAME for a week, showed a minimum alveolar concentration and RRED50 identical to that of untreated wild-type mice. Conclusions: Although acute nonselective inhibition of nitric oxide synthase reduces the anesthetic requirements of wild-type mice, a chronic congenital deficiency of neuronal nitric oxide synthase or a week of L-NAME treatment of wild-type mice does not produce a state of greater sensitivity to the effects of isoflurane anesthesia.Keywords
This publication has 33 references indexed in Scilit:
- Nitric oxide (NO) and nociceptive processing in the spinal cordPain, 1993
- Neurons that say NOTrends in Neurosciences, 1992
- Nitric oxide, a novel biologic messengerCell, 1992
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991
- A Kainate Receptor Linked to Nitric Oxide Synthesis from ArginineJournal of Neurochemistry, 1989
- Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.Proceedings of the National Academy of Sciences, 1989
- NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slicesEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brainNature, 1988
- EFFECT OF ENFLURANE ON CEREBELLAR cGMP AND ON MOTOR ACTIVITY IN THE MOUSEBritish Journal of Anaesthesia, 1983
- In vivo effects of pentobarbital and halothane anesthesia on levels of adenosine 3', 5'-monophosphate and guanosine 3',5'-monophosphate in rat brain regions and pituitaryBiochemical Pharmacology, 1980